hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

NCT00285194 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Hypoglycemia

Interventions

DRUG: Allogeneic Islets of Langerhans
DRUG: hOKT3γ1 (Ala-Ala)

Sponsor

University of Minnesota

Collaborators

[object Object]